NeuFit introduces a new approach to treating neuropathy

NeuFit has unveiled an innovative approach for treating neuropathy that integrates advanced diagnostics and therapeutic technologies.

The NEUBIE (Neuro-Bio-Electric Stimulator) is a device that utilises direct current (DC) electrical stimulation to promote accelerated recovery, enhance performance, and improve overall wellbeing.

Unlike conventional methods that primarily focus on structural rehabilitation, the NEUBIE targets the nervous system, the body’s control centre for responses to injury or dysfunction.

The use of DC over traditional alternating current (AC) in the NEUBIE device sets NeuFit apart from other electrical stimulation therapies.

“Neuropathy is incredibly common among the aging population, regardless of disease states. There is currently no known cure for neuropathy, and most treatments address acute symptoms with no lasting impact,” says Dr. Ramona von Leden, VP of Research and Clinical Affairs for NeuFit.

“NeuFit’s specialized approach to rehab focuses on supporting the function of the nervous system, and we are very excited to share that we are seeing remarkable results on patients with neuropathy.”

Collaborating with HODS to address neuropathy

Neuropathy, characterised by nerve damage that results in pain, weakness, and numbness, presents significant treatment challenges.

HODS specialises in electromyography (EMG) and nerve conduction studies, providing detailed insights into nerve function.

By integrating these diagnostic tools with NeuFit’s therapeutic approach, patients receive comprehensive evaluations and tailored treatment plans that can be adjusted in real-time for optimal results.

A recent clinical trial comparing the NEUBIE device to traditional transcutaneous electrical nerve stimulation (TENS) devices for treating diabetic peripheral neuropathy showed striking results. NEUBIE significantly improved pain reduction, motor function, sensory deficits, and nerve conduction, while TENS showed no significant improvements.

“The findings from this study show that we can make tangible improvements to nerve function and related subjective measures in patients suffering from neuropathy,” said Dr. von Leden.

“NeuFit’s innovative approach, combined with HODS’ diagnostic expertise, is redefining neurological rehabilitation. By focusing on the nervous system and leveraging advanced technology, NeuFit offers a promising future for patients with challenging conditions like neuropathy.”